Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Aspen vs Rejuve Meds

Aspen
Graded #372

Lower grade

vs+7.699999999999996
Rejuve Meds
Graded #208

Higher grade

The verdict

Rejuve Meds takes it — 66.1/100 to 58.4/100.

Rejuve Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Rejuve Meds (Rejuve, Inc.) is a GLP-1 weight-loss telehealth service offering doctor-guided compounded semaglutide at $165/mo and dual-action compounded tirzepatide (GLP-1/GIP) at $265/mo, with no…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueRejuve Meds +38
27
65
Dose & formulationEven
64
64
Clinical oversightAspen +1
80
79
Labs & monitoringEven
52
52
FulfillmentAspen +23
94
71
Contract termsRejuve Meds +14
47
61
Aspen · left barRejuve Meds · right bar

The numbers

MetricAspenRejuve Meds
WeighScore58.4/10066.1/100
GradeCC
Scorecard rank#372#208
Semaglutide$279/mo (3-month plan, compounded)$165/mo (starting dose, compounded)
Tirzepatide$399/mo (compounded)$265/mo (starting dose, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Aspen

Graded #372 · C

Strengths

  • LegitScript-certified with an independently verifiable seal (#50306023) and HIPAA compliance — a strong trust signal for a compounded-GLP-1 telehealth
  • Names its dispensing pharmacy: Red Rock Compounding Pharmacy, LegitScript-certified and NABP-accredited, licensed in 49 states plus DC
  • Flat pricing at every dose ("same price at every dose, no surprises") plus free expedited shipping, so your cost won't rise as you titrate up
  • Competitive prepay rates — compounded semaglutide as low as $179/mo (12-mo) and tirzepatide $299/mo — with zero interest and no credit check
  • Money-back guarantee for qualifying patients who complete the full 28-week program without losing weight; available in all 50 states + DC

Where it loses points

  • Compounded semaglutide and tirzepatide only — no brand-name Wegovy, Zepbound or Ozempic — and compounded GLP-1s aren't FDA-reviewed or approved
  • Even the "monthly" plan requires a 3-month commitment with three months of medication shipped and billed upfront — limited month-to-month flexibility
  • Standing month-to-month pricing is steep ($279 semaglutide, $399 tirzepatide); the lowest rates require 6- or 12-month prepay
  • The provider chooses semaglutide vs tirzepatide for you, so you can't freely pick your own molecule
  • Registered as Aspen Health Systems LLC at a Sheridan, WY address; async model with no routine video visit
Rejuve Meds

Graded #208 · C

Strengths

  • Transparent published pricing: compounded semaglutide $165/mo, tirzepatide $265/mo
  • No membership fees — everything is included; free shipping
  • HSA/FSA eligible; intro pricing from $85 for the first month
  • Doctor-guided programs with personalized care
  • Names a "Rejuve Meds Pharmacy Network" for fulfillment

Where it loses points

  • Individual compounding pharmacies not named (only a "pharmacy network")
  • Prescribing medical group not named
  • States of operation not published
  • Not LegitScript-certified (no certification displayed)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard